Literature DB >> 34913013

Dependence on permanent pacemakers inserted after transcatheter aortic valve implantation: predictive factors in a ten-year retrospective analysis: Rates and predictors of pacemaker dependence after TAVI.

Lance Ng1, Rajesh Nair1, Faeez Ali1, Sanjeevan Pasupati1.   

Abstract

AIMS: The requirement for a permanent pacemaker (PPM) is an important sequela after transcatheter aortic valve implantation (TAVI). The aim of this analysis was to identify predictive factors for pacemaker dependence in PPM-insertions post-TAVI. METHODS AND
RESULTS: A retrospective analysis of all PPM insertions done between January 2009 and December 2018 (n=1,373) identified 33 patients who received a PPM within one month of TAVI. Thirty-two had completed a PPM check at one year and were included in the final analyses. Of those who had PPM insertions after TAVI, 41% (13/32) were not PPM-dependent at one year. This cohort was predominantly European (94%) and over half were octogenerians (56%). Statistically significant associations with being PPM-dependent at one year include intraoperative PPM dependence (OR 5.714 [95% CI: 1.163-28.070]; p=0.032), third-degree heart block being the indication for PPM insertion (OR 8.533 [95% CI: 1.616-45.063]; p=0.012) and mean valve depth over 6.0 mm (OR 6.222 [95% CI: 1.200-32.273]; p=0.030).
CONCLUSIONS: A significant number of patients are not dependent on the PPMs inserted after TAVI. Although small, our study suggests that those who are pacing-dependent intraoperatively, have a third-degree heart block as their PPM indication or have a mean valve depth of over 6.0 mm, are more likely to be pacing-dependent in the long term. Larger studies are required to draw more definitive conclusions.

Entities:  

Year:  2021        PMID: 34913013      PMCID: PMC8658553          DOI: 10.4244/AIJ-D-21-00020

Source DB:  PubMed          Journal:  AsiaIntervention        ISSN: 2426-3958


  18 in total

1.  Completeness of ANZACS-QI Cardiac Implanted DEVICE Registry and agreement with national datasets: ANZACS-QI 30.

Authors:  Fang Shawn Foo; Mildred Lee; David Heaven; Nigel Lever; Susan Sinclair; Martin K Stiles; Scott Harding; Dean Boddington; Peter Larsen; Rod Jackson; Andrew J Kerr
Journal:  N Z Med J       Date:  2019-08-16

Review 2.  Pacemaker implantation after transcatheter aortic valve: why is this still happening?

Authors:  Stefan Toggweiler; Richard Kobza
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

3.  A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.

Authors:  Yoshio Maeno; Yigal Abramowitz; Hiroyuki Kawamori; Yoshio Kazuno; Shunsuke Kubo; Nobuyuki Takahashi; Geeteshwar Mangat; Kazuaki Okuyama; Mohammad Kashif; Tarun Chakravarty; Mamoo Nakamura; Wen Cheng; John Friedman; Daniel Berman; Raj R Makkar; Hasan Jilaihawi
Journal:  JACC Cardiovasc Imaging       Date:  2017-04-12

4.  Inverse Relationship Between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation.

Authors:  Ashraf Hamdan; Victor Guetta; Robert Klempfner; Eli Konen; Ehud Raanani; Michael Glikson; Orly Goitein; Amit Segev; Israel Barbash; Paul Fefer; Dan Spiegelstein; Ilan Goldenberg; Ehud Schwammenthal
Journal:  JACC Cardiovasc Interv       Date:  2015-08-17       Impact factor: 11.195

5.  The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI.

Authors:  Oholi Tovia-Brodie; Yael Ben-Haim; Erel Joffe; Ariel Finkelstein; Aharon Glick; Raphael Rosso; Bernard Belhassen; Yoav Michowitz
Journal:  J Interv Card Electrophysiol       Date:  2016-12-17       Impact factor: 1.900

6.  Depth of valve implantation, conduction disturbances and pacemaker implantation with CoreValve and CoreValve Accutrak system for Transcatheter Aortic Valve Implantation, a multi-center study.

Authors:  Guy D Lenders; Valérie Collas; José Maria Hernandez; Victor Legrand; Haim D Danenberg; Peter den Heijer; Inez E Rodrigus; Bernard P Paelinck; Christiaan J Vrints; Johan M Bosmans
Journal:  Int J Cardiol       Date:  2014-08-01       Impact factor: 4.164

7.  Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.

Authors:  Chekrallah Chamandi; Marco Barbanti; Antonio Munoz-Garcia; Azeem Latib; Luis Nombela-Franco; Enrique Gutiérrez-Ibanez; Gabriela Veiga-Fernandez; Asim N Cheema; Ignacio Cruz-Gonzalez; Vicenç Serra; Corrado Tamburino; Antonio Mangieri; Antonio Colombo; Pilar Jiménez-Quevedo; Jaime Elizaga; Gerard Laughlin; Dae-Hyun Lee; Bruno Garcia Del Blanco; Tania Rodriguez-Gabella; Josep-Ramon Marsal; Mélanie Côté; François Philippon; Josep Rodés-Cabau
Journal:  JACC Cardiovasc Interv       Date:  2018-02-12       Impact factor: 11.195

8.  Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function.

Authors:  Marina Urena; John G Webb; Corrado Tamburino; Antonio J Muñoz-García; Asim Cheema; Antonio E Dager; Vicenç Serra; Ignacio J Amat-Santos; Marco Barbanti; Sebastiano Immè; Juan H Alonso Briales; Luis Miguel Benitez; Hatim Al Lawati; Angela Maria Cucalon; Bruno García Del Blanco; Javier López; Eric Dumont; Robert Delarochellière; Henrique B Ribeiro; Luis Nombela-Franco; François Philippon; Josep Rodés-Cabau
Journal:  Circulation       Date:  2013-12-26       Impact factor: 29.690

Review 9.  Use of Electrophysiological Studies in Transcatheter Aortic Valve Implantation.

Authors:  Oholi Tovia-Brodie; Yoav Michowitz; Bernard Belhassen
Journal:  Arrhythm Electrophysiol Rev       Date:  2020-06-03

10.  Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial.

Authors:  Christopher U Meduri; Dean J Kereiakes; Vivek Rajagopal; Raj R Makkar; Daniel O'Hair; Axel Linke; Ron Waksman; Vasilis Babliaros; Robert C Stoler; Gregory J Mishkel; David G Rizik; Vijay S Iyer; John Schindler; Dominic J Allocco; Ian T Meredith; Ted E Feldman; Michael J Reardon
Journal:  J Am Heart Assoc       Date:  2019-10-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.